[go: up one dir, main page]

AR034435A1 - Agentes terapeuticos. - Google Patents

Agentes terapeuticos.

Info

Publication number
AR034435A1
AR034435A1 ARP020102152A ARP020102152A AR034435A1 AR 034435 A1 AR034435 A1 AR 034435A1 AR P020102152 A ARP020102152 A AR P020102152A AR P020102152 A ARP020102152 A AR P020102152A AR 034435 A1 AR034435 A1 AR 034435A1
Authority
AR
Argentina
Prior art keywords
therapeutic agents
organic acid
steroidal anti
inflammatory drug
formulation comprises
Prior art date
Application number
ARP020102152A
Other languages
English (en)
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of AR034435A1 publication Critical patent/AR034435A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Formulación farmacéutica adaptada para desintegrarse rápidamente en la boca. La formulación comprende un fármaco antiinflamatorio no esteroide de bajo punto de fusión y un ácido orgánico, donde la formulación comprende: (a) una composición granulada que comprende una pluralidad de gránulos de la fusión solidificada de dicho fármaco antiinflamatorio no esteroide y (b) un ácido orgánico.
ARP020102152A 2001-06-07 2002-06-07 Agentes terapeuticos. AR034435A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0113843.7A GB0113843D0 (en) 2001-06-07 2001-06-07 Therapeutic agents

Publications (1)

Publication Number Publication Date
AR034435A1 true AR034435A1 (es) 2004-02-25

Family

ID=9916084

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020102152A AR034435A1 (es) 2001-06-07 2002-06-07 Agentes terapeuticos.

Country Status (8)

Country Link
EP (1) EP1392240B1 (es)
AR (1) AR034435A1 (es)
AT (1) ATE518521T1 (es)
ES (1) ES2369137T3 (es)
GB (1) GB0113843D0 (es)
HK (1) HK1061205A1 (es)
PT (1) PT1392240E (es)
WO (1) WO2002098387A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0113841D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
JP4633469B2 (ja) 2002-12-16 2011-02-16 キッセイ薬品工業株式会社 経口固形医薬
PL1799195T3 (pl) * 2004-08-12 2016-09-30 Granulki zawierające paracetamol, nlpz i alkohol cukrowy wytwarzane przez wytłaczanie ze stopionego materiału
US20080113021A1 (en) * 2006-10-25 2008-05-15 Robert Shen Ibuprofen composition
WO2010020772A2 (en) * 2008-08-22 2010-02-25 Reckitt Benckiser Healthcare (Uk) Limited Improvements in or relating to compositions
IT1406107B1 (it) * 2010-12-13 2014-02-14 Alfa Wassermann Spa Composizioni solide comprendenti antiinfiammatori non steroidei, processi per la loro preparazione e loro uso.
WO2013093941A2 (en) * 2011-12-21 2013-06-27 Talwar Research Foundation Compositions comprising probiotic lactobacillus strains for improved vaginal health
RS59351B1 (sr) * 2014-05-01 2019-10-31 Hermes Arzneimittel Gmbh Čvrste oralne formulacije koje sadrže čvrste rastopljene disperzije organskih kiselina u ksilitolu

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW442287B (en) 1995-06-13 2001-06-23 American Home Produits Corp Organoleptically acceptable oral pharmaceutical composition comprising the S(+)1,8-diethyl-1-1,3,4,9-tetrahydropyrano[3,4-b] indole-1-acetic acid (Etodolac)
NZ333474A (en) * 1998-01-02 1999-06-29 Mcneil Ppc Inc A chewable tablet containing ibuprofen, fumaric acid and a non hydrocolloid binder e.g. a wax or a fat
KR20010041609A (ko) * 1998-03-06 2001-05-25 유란드 인터내셔날 에스.피.아. 속해성 정제
HU227045B1 (en) * 1999-12-09 2010-05-28 Reckitt Benckiser Healthcare Compressed tablet composition comprising a nsaid

Also Published As

Publication number Publication date
WO2002098387A1 (en) 2002-12-12
PT1392240E (pt) 2011-10-12
ES2369137T3 (es) 2011-11-25
EP1392240B1 (en) 2011-08-03
ATE518521T1 (de) 2011-08-15
HK1061205A1 (en) 2004-09-10
EP1392240A1 (en) 2004-03-03
GB0113843D0 (en) 2001-08-01

Similar Documents

Publication Publication Date Title
UY26306A1 (es) Composición para la dosificación oral, de disolución instantanea
RS50303B (sr) Farmaceutska kompozicija nimesulida sa kontrolisanim oslobađanjem
PA8575701A1 (es) Preparaciones acidas de insulina con estabilidad mejorada
ECSP045102A (es) Formulación farmacéutica que contiene 3-(3-dimetilamino-1-etil-2-metil-propil)fenol y proporciona una liberación retardada del ingrediente activo
ATE324104T1 (de) Mesalazine enthaltende pharmazeutische zusammensetzungen mit gesteuerter freisetzung
ITMI20011337A0 (it) Composizioni farmaceutiche orali a rilascio modificato del principio attivo
AR038527A1 (es) Forma de dosificacion que contiene un inhibidor de la pde 4 como ingrediente activo
NO20011471D0 (no) Nye orale vedvarende frigivelsesformuleringer
PT1339675E (pt) Compostos bisarilo orto, meta-substituidos, processo para a sua preparacao, sua utilizacao como medicamentos e composicoes farmaceuticas que os contem
AR037490A1 (es) Composiciones farmaceuticas solidas, proceso para su preparacion, kit para el tratamiento de la obesidad y uso de dichas composiciones en la elaboracion de medicamentos
IS6348A (is) (1a,3a,5a)(3-amínómetýl bísýkló[3.2.0]hept-3-ýl)-ediksýra, lyfjasamsetningar og notkun efnasambandsins til framleiðslu á lyfjum
NO20084065L (no) Hurtig frigivelses paracetamol tabletter
RS52777B (en) CURRENT RELEASE THERAPY SYSTEM FOR IMPROVED ORAL ABSORPTION 7 - [(E) -TERT-BUTYLOXYIMINOMETHYL] CAMPTOTECIN
WO2007143163A3 (en) Pharmaceutical compositions for sustained release of phenyephrine
NO20023551D0 (no) Ibuprofen-inneholdende aktivt middel-preparat
ID28510A (id) Formulasi oral yang baru untuk agonis atau antagonis 5-ht4
AR034435A1 (es) Agentes terapeuticos.
DE69927374T2 (de) Entzündungshemmende pharmazeutische formulierungen
MXPA06011467A (es) Combinacion de sustancias activas que comprenden un carbinol combinado con al menos un farmaco antiinflamatorio no esteroideo (nsaid).
AR034437A1 (es) Agentes terapeuticos.
AR034436A1 (es) Agentes terapeuticos.
AR033896A1 (es) Preparaciones granuladas de gaboxadol.
DE60103276D1 (de) Eine stabile pharmazeutische formulierung die torsemid modifikation ii enthält
CL2003002588A1 (es) Uso de una composicion farmaceutica que comprende acido n,n-dimetoximetildifenil barbiturico, acido n-metoximetildifenil barbiturico o acido difenil barbiturico o una sal farmaceuticamente aceptable del mismo para preparar un medicamento util en el t
WO2002022107A3 (en) Pharmaceutical composition having modified carrier

Legal Events

Date Code Title Description
FA Abandonment or withdrawal